SynCo’s multi-purpose GMP facilities offer manufacturing capabilities for microbial based biopharmaceuticals (such as proteins and vaccines) for worldwide supply according to the highest quality standards.
SynCo is world leader in Live Microbial projects, which refers to products containing whole, live microorganisms, such as bacteria or yeast with an intended therapeutic or preventive effect in humans.
SynCo has broad experience in aseptic filling and lyophilization of biotherapeutics and offers a ‘one stop shop’, in a full state-of-the-art fill and finish facility, located in the same building where the drug substance manufacturing occurs.
5th Microbiome R&D and Business Collaboration Forum: USA. 2–3 November 2017. San Diego, United States. For more information, see page
SynCo Bio Partners
All rights reserved. © 2018 | Terms | Privacy